Bahrain vs Guam: Tuberculosis patients living with HIV receiving antiretroviral therapy
Bahrain
1 patients
in 2021
Guam
1 patients
in 2021
Bahrain rank
130th
Guam rank
130th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Bahrain
- Guam
How they compare
Bahrain currently reports 1 patients against 1 patients in Guam, a difference of 0 patients.
The two have swapped places 4 times across 17 shared years of data; in 2003 it was Guam ahead.
Bahrain ranks 130th and Guam ranks 130th of 183 countries.
Bahrain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahrain | Guam | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.1429 patients | 0.1429 patients | 0 patients | — |
| 2010s | 1.88 patients | 0.375 patients | 1.5 patients | Bahrain |
| 2020s | 2 patients | 0.5 patients | 1.5 patients | Bahrain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Bahrain or Guam?
- Bahrain, at 1 patients against 1 patients in Guam as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Bahrain and Guam?
- 0 patients, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Guam?
- 17 years are reported by both, from 2003 to 2021.
- How do Bahrain and Guam rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Bahrain ranks 130th and Guam ranks 130th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.